Common questions about Iflo (FAQ)
Q: Is Iflo used for long-term or short-term treatment?
A: Regulatory documentation suggests that this medication is generally intended for continuous, long-term use. The maximum recommended dose is designed for this ongoing treatment. Clinical study data for certain formulations have been gathered for administration lasting up to 40 months.
Q: How often do people typically report mild side effects from Iflo?
A: Official information derived from clinical trials indicates the most commonly reported adverse reaction was ocular burning, which occurred in approximately 17% of patients. Other reactions like conjunctival redness, discharge, eye pain, and blurred vision were reported in a lower percentage of patients (1% to 5%).
Q: How quickly does Iflo usually start working after the first dose?
A: Because this medication works by modulating the immune response at the cellular level, its intended effects are gradual. Clinical studies for dry eye disease observed changes in tear production over the course of treatment, with significant changes typically noted after about six months, reflecting the gradual nature of its mechanism.
Q: Can Iflo be used in children, and if so, at what age?
A: The established age of use varies depending on the specific condition being treated. For dry eye disease, one FDA-approved formulation is indicated for children 16 years of age and older. However, a different formulation used for vernal keratoconjunctivitis (VKC) is approved for children 4 years of age and older in the US and Europe.
Q: What is the risk classification for Iflo during pregnancy?
A: Official prescribing information states there are no adequate and well-controlled studies of the eye drops in pregnant women. Given the medication’s undetectable systemic exposure, official documentation states that the medication should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as determined by a healthcare professional.
Q: Is it normal to feel a mild headache after starting Iflo?
A: Headache is listed as a systemic adverse reaction in the official product labeling and was reported in a small percentage (up to 7%) of patients in clinical trials. Any concerns about ongoing headaches should be directed to a healthcare professional.
Q: Do the side effects of Iflo usually go away over time?
A: Adverse reactions reported for the eye drops are generally expected to be localized (in the eye), transitory, and mild to moderate in severity. This means that symptoms like burning or stinging are typically temporary.
Q: How long does Iflo stay in the system after the last dose?
A: Because this medication is applied topically to the eye, its systemic exposure is negligible. Blood concentrations of the active ingredient were not detectable in human subjects after using the product for up to 12 months. This indicates that the drug does not build up or stay in the bloodstream.
Q: What is the maximum amount of time a person should be on Iflo, according to official documents?
A: The maximum recommended dose is intended for continuous long-term treatment. Regulatory documents state that clinical study data exists for administration of the product for up to 40 months.
Q: Is Iflo part of a larger treatment plan, or is it used alone?
A: Official guidance confirms that Iflo can be used at the same time as artificial tears (lubricant eye drops). A 15-minute interval must be observed between the application of the two products to prevent one from washing out the other.
Q: Is it true that Iflo can cause joint pain?
A: Joint pain is not listed among the adverse reactions commonly reported or otherwise cited in the clinical trials for this ophthalmic product. Official information does not confirm this as an expected effect.
Q: Does Iflo have a specific classification regarding driving or operating machinery?
A: Yes, official guidance warns that the eye drops may cause transient blurred vision or other temporary vision problems. The official warning states that operating machinery or driving should be avoided until any temporary visual disturbance has resolved.
Q: Does Iflo have any ingredients that people with common food allergies should be aware of?
A: The inactive ingredients are explicitly listed in the official product description. These typically include components such as castor oil, polysorbate 80, and glycerin, among others.
Q: What should be done if I feel dizzy after taking Iflo?
A: Official patient counseling information advises that if you experience blurred vision or any other vision problem after applying the drops, you should not drive or do anything that requires clear vision until the effect passes. Any concerns or adverse effects should be addressed by consulting a healthcare professional.
Q: Does Iflo contain lactose or gluten?
A: No, the inactive ingredients listed in the official product description for the ophthalmic emulsion or solution do not include lactose or gluten.
Q: What is the purpose of the 'inactive ingredients' listed in Iflo?
A: Inactive ingredients are components that are essential for the physical properties of the medicine. They are used to formulate the product as a sterile emulsion or solution, giving it the correct consistency (viscosity), pH, and other characteristics needed for safe and effective use in the eye.
Q: Does Iflo cause drowsiness?
A: The official product information does not list drowsiness as an adverse reaction. However, a warning is included regarding the potential for transient blurred vision or other vision problems that may temporarily affect your ability to operate machinery.
Q: Does Iflo affect fertility?
A: Nonclinical animal studies using high oral doses of the active ingredient found no adverse effects on fertility in male and female rats. Because human systemic exposure is undetectable and animal studies showed no adverse effects on fertility, no specific risk to human fertility is established.
